Similarly, the proportion of shared c-MYC/MYCN target genes and markers in development and disease with prognostic power was significantly high for murine sympathoadrenal development and NB comparisons, yet it was not in complete correlation with the results for patients (Fisher exact test, one-tail, FDR < 0.05, Figure S9a–e). This evidence concerns the gene MYCN and neuroblastoma.